TY  - CHAP
M1  - Book, Section
TI  - Syphilis, Gonorrhea, & Chlamydia Trachomatis Infection in Pregnancy
A1  - Rogers, Vanessa L.
A1  - Roberts, Scott W.
A2  - Papadakis, Maxine A.
A2  - McPhee, Stephen J.
A2  - Rabow, Michael W.
A2  - McQuaid, Kenneth R.
PY  - 2023
T2  - Current Medical Diagnosis & Treatment 2023
AB  - These  STDs  have  significant  consequences  for  mother  and  child  (see  also  Chapters  33  and  34).  Untreated  syphilis  in  pregnancy  can  cause  late  abortion,  stillbirth,  transplacental  infection,  and  congenital  syphilis.  Gonorrhea  can  produce  large-joint  arthritis  by  hematogenous  spread  as  well  as  ophthalmia  neonatorum.  Maternal  chlamydial  infections  are  largely  asymptomatic  but  are  manifested  in  the  newborn  by  inclusion  conjunctivitis  and,  at  age  2–4  months,  by  pneumonia.  The  diagnosis  of  each  can  be  reliably  made  by  appropriate  laboratory  tests.  All  women  should  be  tested  for  syphilis  as  part  of  their  routine  prenatal  care.  Pregnant  women  younger  than  25  years  and  those  at  increased  risk  for  C  trachomatis  should  be  screened  for  chlamydia  at  their  first  prenatal  visit.  Repeat  testing  depends  on  risk  factors,  prevalence,  and  state  laws.  A  pregnant  woman  treated  for  C  trachomatis  should  be  tested  for  cure  4  weeks  later  and  then  retested  3  months  later  because  of  high  reinfection  rates.  Women  who  remain  at  high  risk  should  be  tested  in  the  third  trimester.  Women  younger  than  25  years  and  those  at  increased  risk  should  be  tested  for  gonorrhea  at  their  first  prenatal  appointment.  Women  with  positive  tests  for  gonorrhea  should  be  treated  and  then  retested  3  months  later.  Women  who  remain  at  high  risk  should  be  tested  in  the  third  trimester.  The  sexual  partners  of  women  with  STDs  should  be  identified  and  treated  if  possible;  the  local  health  department  can  assist  with  this  process.  
SN  - 
PB  - McGraw-Hill Education
CY  - New York, NY
Y2  - 2024/04/19
UR  - accessmedicine.mhmedical.com/content.aspx?aid=1193159535
ER  -